Skip to main content
SpringerLink
Log in

Novel botanical drug for the treatment of diabetic neuropathy

  • Report on Investigational Drugs
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Diabetic neuropathy has multiple aspects of pathophysiology including metabolic derangements and alterations of microvessel with hyperglycemia. Currently, there is no effective long-term treatment based on the pathologic mechanisms. Nerve regeneration with nerve growth factor (NGF) has been on clinical trials as a treatment option. This article reviews an action of a herbal medicine, DA 9801, whose mechanism of action is related to NGF in treating diabetic neuropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Boucher, T. J. and McMahon, S. B., Neurotrophic factors and neuropathic pain. Curr. Opin. Pharmacol., 1, 66–72 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Boulton, A. J., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., and Ziegler, D., Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care, 28, 956–962 (2005).

    Article  PubMed  Google Scholar 

  • Datamonitor. Forecast insight: Neuropathic pain (2009). Datamonitor. Pipeline and commercial insight: Neuropathic pain (2011).

  • Edwards, J. L., Vincent, A. M., Cheng, H. T., and Feldman, E. L., Diabetic neuropathy: Mechanisms to management. Pharmacol. Ther., 120, 1–34 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Guastella, V. and Mick, G., Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy. Diabetes Metab., 35, 12–19 (2009).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center of Dong-A Pharm Co., Ltd, Yongin, 446-905, Korea

    Sang-Zin Choi & Mi-Won Son

  2. Dong-A Pharm., 47-5 Sanggal-Dong, Kiheung-Gu, Yongin-Si, Kyunggi-Do, Korea

    Mi-Won Son

Authors
  1. Sang-Zin Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mi-Won Son
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mi-Won Son.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choi, SZ., Son, MW. Novel botanical drug for the treatment of diabetic neuropathy. Arch. Pharm. Res. 34, 865–867 (2011). https://doi.org/10.1007/s12272-011-0621-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-011-0621-2

Keywords

Search

Navigation